Alimera Sciences, Inc. (ALIM) financial statements (2022 and earlier)

Company profile

Business Address 6310 TOWN SQUARE
ALPHARETTA, GA 30005
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,51011,2089,42613,04324,06730,97931,075
Cash and cash equivalents16,51011,2089,42613,04324,06730,97931,075
Restricted cash and investments34343332343137
Receivables19,12817,20019,33117,25911,43513,8399,799
Inventory, net of allowances, customer advances and progress billings2,6792,7461,3902,4051,5084461,552
Inventory2,6792,7461,3902,4051,5084461,552
Other undisclosed current assets3,8093,7182,5652,1092,2782,1072,696
Total current assets:42,16034,90632,74534,84839,32247,40245,159
Noncurrent Assets
Finance lease, right-of-use asset392 414
Operating lease, right-of-use asset1,7107201,107
Property, plant and equipment2,7831,638 1,3551,4101,7872,553
Intangible assets, net (including goodwill)10,89712,83814,78316,72318,66420,60422,549
Intangible assets, net (excluding goodwill)10,89712,83814,78316,72318,66420,60422,549
Deferred income tax assets137753734
Deferred tax assets, net   223
Other undisclosed noncurrent assets441 5261,182528436 
Total noncurrent assets:16,36015,94917,56419,26020,60222,82725,325
TOTAL ASSETS:58,52050,85550,30954,10859,92470,22970,484
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,32310,65811,7939,9989,4878,7447,596
Accounts payable8,7067,4617,0776,3555,9054,9864,002
Accrued liabilities3,6173,1974,7163,6433,5823,7583,594
Debt2691,69025523618419132,020
Derivative instruments and hedges, liabilities     188 
Other undisclosed current liabilities      317
Total current liabilities:12,59212,34812,04810,2349,6719,12339,933
Noncurrent Liabilities
Long-term debt and lease obligation43,08042,9229430534,56833,358582
Long-term debt, excluding current maturities43,08042,408  34,36533,084 
Finance lease, liability 51494
Capital lease obligations305203274582
Liabilities, other than long-term debt5,4533,5633,9542,9747662,162834
Other liabilities5,4533,5633,9542,9747662,162834
Total noncurrent liabilities:48,53346,4854,0483,27935,33435,5201,416
Total liabilities:61,12558,83316,09613,51345,00544,64341,349
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,605)(7,978)(4,445)2,72214,91925,58626,320
Common stock695750701  450
Additional paid in capital377,229365,830350,117346,108341,622330,781299,376
Accumulated other comprehensive loss(1,849)(553)(1,093)(1,011)(821)(1,272)(1,148)
Accumulated deficit(397,281)(392,909)(387,570)(377,127)(399,075)(377,074)(343,900)
Warrants and rights outstanding 3703,7073,707   
Other undisclosed stockholders' equity attributable to parent19,22719,22730,34430,34473,19373,15171,542
Total stockholders' equity:(2,605)(7,978)(4,445)2,72214,91925,58626,320
Other undisclosed liabilities and equity  38,65837,873  2,815
TOTAL LIABILITIES AND EQUITY:58,52050,85550,30954,10859,92470,22970,484

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues59,02950,82053,94346,97035,91234,33322,438
Cost of revenue
(Cost of Goods and Services Sold)
(7,030)(6,941)(6,626) (3,438)(2,344)(1,762)
Other undisclosed gross profit   (4,679)   
Gross profit:51,99943,87947,31742,29132,47431,98920,676
Operating expenses(52,200)(44,380)(52,591)(51,961)(48,926)(59,836)(59,675)
Operating loss:(201)(501)(5,274)(9,670)(16,452)(27,847)(38,999)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
416474(84)(65)5(40)(106)
Interest and debt expense(3,621)(5,380)(4,869)(6,541)(5,579)(7,742)(4,693)
Other undisclosed income from continuing operations before equity method investments, income taxes    1882,62713,283
Loss from continuing operations before equity method investments, income taxes:(3,406)(5,407)(10,227)(16,276)(21,838)(33,002)(30,515)
Other undisclosed loss from continuing operations before income taxes(528)      
Loss from continuing operations before income taxes:(3,934)(5,407)(10,227)(16,276)(21,838)(33,002)(30,515)
Income tax expense (benefit)(438)68(216)(106)(163)(172)(130)
Net loss attributable to parent:(4,372)(5,339)(10,443)(16,382)(22,001)(33,174)(30,645)
Preferred stock dividends and other adjustments   38,330   
Undistributed earnings (loss) allocated to participating securities, basic   4,489 
Other undisclosed net loss available to common stockholders, basic   (4,489)   
Net income (loss) available to common stockholders, diluted:(4,372)(5,339)(10,443)21,948(22,001)(33,174)(30,645)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(4,372)(5,339)(10,443)(16,382)(22,001)(33,174)(30,645)
Other comprehensive income (loss)  (82)(190)451(124)(336)
Comprehensive loss:(4,372)(5,339)(10,525)(16,572)(21,550)(33,298)(30,981)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,296)540     
Comprehensive loss, net of tax, attributable to parent:(5,668)(4,799)(10,525)(16,572)(21,550)(33,298)(30,981)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: